Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.
Navid F, Herzog CE, Sandoval J, Daryani VM, Stewart CF, Gattuso J, Mandrell B, Phipps S, Chemaitilly W, Sykes A, Davidoff AM, Shulkin BL, Bahrami A, Furman WL, Mao S, Wu J, Schiff D, Rao B, Pappo A. Navid F, et al. Among authors: mao s. Pediatr Blood Cancer. 2016 Jul;63(7):1207-13. doi: 10.1002/pbc.25983. Epub 2016 Apr 1. Pediatr Blood Cancer. 2016. PMID: 27038395 Free PMC article. Clinical Trial.
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma.
Federico SM, McCarville MB, Shulkin BL, Sondel PM, Hank JA, Hutson P, Meagher M, Shafer A, Ng CY, Leung W, Janssen WE, Wu J, Mao S, Brennan RC, Santana VM, Pappo AS, Furman WL. Federico SM, et al. Among authors: mao s. Clin Cancer Res. 2017 Nov 1;23(21):6441-6449. doi: 10.1158/1078-0432.CCR-17-0379. Epub 2017 Sep 22. Clin Cancer Res. 2017. PMID: 28939747 Free PMC article. Clinical Trial.
Safety and diagnostic accuracy of tumor biopsies in children with cancer.
Interiano RB, Loh AH, Hinkle N, Wahid FN, Malkan AD, Bahrami A, Jenkins JJ, Mao S, Wu J, Proctor K, Santana VM, Pappo AS, Gold RE, Davidoff AM. Interiano RB, et al. Among authors: mao s. Cancer. 2015 Apr 1;121(7):1098-107. doi: 10.1002/cncr.29167. Epub 2014 Dec 18. Cancer. 2015. PMID: 25524504 Free PMC article.
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.
Navid F, Santana VM, Neel M, McCarville MB, Shulkin BL, Wu J, Billups CA, Mao S, Daryani VM, Stewart CF, Kunkel M, Smith W, Ward D, Pappo AS, Bahrami A, Loeb DM, Reikes Willert J, Rao BN, Daw NC. Navid F, et al. Among authors: mao s. Int J Cancer. 2017 Oct 1;141(7):1469-1477. doi: 10.1002/ijc.30841. Epub 2017 Jul 3. Int J Cancer. 2017. PMID: 28631382 Free PMC article. Clinical Trial.
Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours.
Federico SM, Caldwell KJ, McCarville MB, Daryani VM, Stewart CF, Mao S, Wu J, Davidoff AM, Santana VM, Furman WL, Pappo AS, Navid F. Federico SM, et al. Among authors: mao s. Eur J Cancer. 2020 Jun;132:35-42. doi: 10.1016/j.ejca.2020.03.010. Epub 2020 Apr 20. Eur J Cancer. 2020. PMID: 32325418 Free PMC article. Clinical Trial.
3,351 results